智通财经APP获悉,1月15日,据药明康德(02359)在摩根大通医疗健康年会(JPM)的演示材料显示,持续强劲的经营现金流将用于推进全球产能及能力建设,预计2025年D&M资本支出将翻番。
根据材料显示,在全球范围内药明康德至少有6处在扩建或正在建设的基地。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.